Advertisement

Breast Cancer Risk Assessment and Screening in Transgender Patients

Published:August 24, 2016DOI:https://doi.org/10.1016/j.clbc.2016.08.003
      Cases of breast cancer have been reported in transgender patients; however, because this occurrence is so rare, no evidence-based screening guidelines exist for this complicated patient population, and there are no formal recommendations for surgery selection in this population.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Breast Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Conron K.J.
        • Landers S.J.
        • Reisner S.L.
        • et al.
        Sex and gender in the US health surveillance system: a call to action.
        Am J Public Health. 2014; 104: 970-976
        • Conron K.J.
        • Scott G.
        • Stowell G.S.
        • et al.
        Transgender health in Massachusetts: results from a household probability sample of adults.
        Am J Public Health. 2012; 102: 118-122
        • Bazzi A.R.
        • Whorms D.S.
        • King D.S.
        • et al.
        Adherence to mammography screening guidelines among transgender persons and sexual minority women.
        Am J Public Health. 2015; 105: 2356-2358
        • Unger C.A.
        Care of the transgender patient: a survey of gynecologists' current knowledge and practice.
        J Womens Health. 2015; 24: 114-118
        • Sattari M.
        Breast cancer in male-to-female transgender patients: a case for caution.
        Clin Breast Cancer. 2015; 15: e67-e69
        • Gooren L.J.
        • van Trotsenburg M.A.
        • Giltay E.J.
        • et al.
        Breast cancer development in transsexual subjects receiving cross-sex hormone treatment.
        J Sex Med. 2013; 10: 3129-3134
        • Brown G.R.
        Breast cancer in transgender veterans: a ten-case series.
        LGBT Health. 2015; 2: 77-80
        • Gooren L.J.
        Management of female-to-male transgender persons: medical and surgical management, life expectancy.
        Curr Opin Endocrinol Diabetes Obes. 2014; 21: 233-238
        • Shao T.
        • Grossbard M.L.
        • Klein P.
        Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management.
        Clin Breast Cancer. 2011; 11: 417-419
        • Dimitrakakis C.
        • Bondy C.
        Androgens and the breast.
        Breast Cancer Res. 2009; 11: 212
        • Bentz E.K.
        • Pils D.
        • Bilban M.
        • et al.
        Gene expression signatures of breast tissue before and after cross-sex hormone therapy in female-to-male transsexuals.
        Fertil Steril. 2010; 94: 2688-2696
        • Phillips J.
        • Fein-Zachary V.J.
        • Mehta T.S.
        • et al.
        Breast imaging in the transgender patient.
        AJR Am J Roentgenol. 2014; 202: 1149-1156
        • Veronesi P.
        • De Lorenzi F.
        • Loschi P.
        • et al.
        Current trends in the oncologic and surgical managements of breast cancer in women with implants: incidence, diagnosis, and treatment.
        Aesthetic Plast Surg. 2016; 40: 256-265
        • Nikolic D.V.
        • Djordjevic M.L.
        • Granic M.
        • et al.
        Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy.
        World J Surg Oncol. 2012; 10: 280
        • Burcombe R.J.
        • Makris A.
        • Pittam M.
        • et al.
        Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual.
        Breast. 2003; 12: 290-293
        • Bevers T.B.
        Breast cancer prevention: an update of the STAR trial.
        Curr Treat Options Oncol. 2010; 11: 66-69
        • Fentiman I.S.
        Male breast cancer is not congruent with the female disease.
        Crit Rev Oncol Hematol. 2016; 101: 119-124
        • Tice J.A.
        • Cummings S.R.
        • Smith-Bindman R.
        • et al.
        Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.
        Ann Intern Med. 2008; 148: 337-347
        • James P.A.
        • Doherty R.
        • Harris M.
        • et al.
        Optimal selection of individuals for BRCA mutation testing: a comparison of available methods.
        J Clin Oncol. 2006; 24: 707-715
        • Tyrer J.
        • Duffy S.W.
        • Cuzick J.
        A breast cancer prediction model incorporating familial and personal risk factors.
        Stat Med. 2004; 23: 1111-1130
        • Saslow D.
        • Boetes C.
        • Burke W.
        • et al.
        American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
        CA Cancer J Clin. 2007; 57: 75-89
        • Oeffinger K.C.
        • Fontham E.T.
        • Etzioni R.
        • et al.
        Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society.
        JAMA. 2015; 314: 1599-1614
        • Smith R.A.
        • Saslow D.
        • Sawyer K.A.
        • et al.
        American Cancer Society guidelines for breast cancer screening: update 2003.
        CA Cancer J Clin. 2003; 53: 141-169